Bio Essence (BIOE) Equity Average (2020 - 2026)

Bio Essence's Equity Average history runs 7 years deep, the most recent figure standing at -$1.8 million for Q1 2026.

• In Q1 2026, Equity Average rose 43.03% year-over-year to -$1.8 million; the TTM figure through Mar 2026 stood at -$1.8 million (up 43.03% YoY), while the FY2025 annual figure was -$2.5 million, down 8.91% from the prior year.
• Equity Average was -$1.8 million for Q1 2026 at Bio Essence, up from -$2.6 million in the prior quarter.
• In the past five years, Equity Average ranged from a high of -$1.3 million in Q3 2023 to a low of -$3.3 million in Q1 2023.
• Historically, Equity Average has averaged -$2.5 million across 5 years, with a median of -$2.6 million in 2025.
• The sharpest annual moves came in 2023 and 2025: Equity Average jumped 55.25% in 2023, then plunged 92.8% in 2025.
• A 5-year view of Equity Average shows it stood at -$3.1 million in 2022, then surged by 50.08% to -$1.6 million in 2023, then tumbled by 89.02% to -$3.0 million in 2024, then increased by 12.45% to -$2.6 million in 2025, then soared by 32.36% to -$1.8 million in 2026.
• The last three Equity Average figures came in at -$1.8 million (Q1 2026), -$2.6 million (Q4 2025), and -$3.1 million (Q3 2025), per Business Quant data.